The role of interleukin-17 in neurological disorders (2025)
- Authors:
- USP affiliated authors: ULRICH, ALEXANDER HENNING - IQ ; BRITTO, LUIZ ROBERTO GIORGETTI DE - ICB ; FERREIRA, ANA FLAVIA FERNANDES - ICB
- Unidades: IQ; ICB
- DOI: 10.1080/19768354.2025.2510994
- Subjects: FISIOLOGIA; INTERLEUCINAS; TRANSTORNOS MENTAIS; DOENÇAS NEURODEGENERATIVAS; CITOCINAS; DOENÇAS DO SISTEMA NERVOSO CENTRAL
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Animal Cells and Systems
- ISSN: 2151-2485
- Volume/Número/Paginação/Ano: v. 29, n. 1, p. 372-386, 2025
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
PARKA, Seung Eun et al. The role of interleukin-17 in neurological disorders. Animal Cells and Systems, v. 29, n. 1, p. 372-386, 2025Tradução . . Disponível em: https://doi.org/10.1080/19768354.2025.2510994. Acesso em: 31 mar. 2026. -
APA
Parka, S. E., Ferreira, A. F. F., Kwon, H., Yu, J., Diniz, L., Kim, E., et al. (2025). The role of interleukin-17 in neurological disorders. Animal Cells and Systems, 29( 1), 372-386. doi:10.1080/19768354.2025.2510994 -
NLM
Parka SE, Ferreira AFF, Kwon H, Yu J, Diniz L, Kim E, Ulrich H, Britto LRG de. The role of interleukin-17 in neurological disorders [Internet]. Animal Cells and Systems. 2025 ; 29( 1): 372-386.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1080/19768354.2025.2510994 -
Vancouver
Parka SE, Ferreira AFF, Kwon H, Yu J, Diniz L, Kim E, Ulrich H, Britto LRG de. The role of interleukin-17 in neurological disorders [Internet]. Animal Cells and Systems. 2025 ; 29( 1): 372-386.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1080/19768354.2025.2510994 - Deletion of the transient receptor potential melastatin 2 gene mitigates the 6-hyydroxydopamine-induced Parkinson’s Disease–Like Pathology
- Deletion of the transient receptor potential Melastatin 2 gene mitigates the 6-hydroxydopamine-induced parkinson’s disease–like pathology
- Neurodegeneration and glial morphological changes are both prevented by TRPM2 inhibition during the progression of a Parkinson's disease mouse model
- Inhibition of neuroinflammation by GIBH-130 (AD-16) reduces neurodegeneration, motor deficits, and proinflammatory cytokines in a hemiparkinsonian model
- The transient receptor potential melastatin 2: a new therapeutical target for Parkinson’s disease?
- Therapeutic potential of KATP channels in the attenuation of Parkinson's disease pathogenesis and progression: a review
- Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson’s Disease animal model
- Proliferation and differentiation of embryonic cells to neurons depende on purinergic receptor-induced calcium transients
- Carvacrol promotes neuroprotection in the mouse hemiparkinsonian model
- Pharmacological properties of purinergic receptors and their effects on proliferation and induction of neuronal differentiation of P19 embryonal carcinoma cells
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
